MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.
MiMARK has raised $394K in total funding. The most recent round was Seed. The last funding was announced in September 2025.
MiMARK's investors include Inveready, CDTI Innovación's INNVIERTE program, EIC Accelerator, Clave Capital, PharmStars.
MiMARK is headquartered in Barcelona, Spain.
MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.
MiMARK is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MiMARK — Funding & Investors." VCBacked, September 17, 2025, https://www.vcbacked.co/company/mimark. Accessed July 19, 2026.
VCBacked. (2025). MiMARK — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/mimark
{{cite web |title=MiMARK — Funding & Investors |url=https://www.vcbacked.co/company/mimark |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated